Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Figure 1 from Dual mTORC1/2 Inhibition Sensitizes Testicular Cancer Models to Cisplatin Treatment
  1. Home
  2. Publications
  3. Supplementary Figure 1 from Dual mTORC1/2 Inhibition Sensitizes Testicular Cancer Models to Cisplatin Treatment

Supplementary Figure 1 from Dual mTORC1/2 Inhibition Sensitizes Testicular Cancer Models to Cisplatin Treatment

Authors:
  • XRXimena Rosas-Plaza
    Ximena Rosas-Plaza
  • GVGerda de Vries
    Gerda de Vries
  • GMGert Jan Meersma
    Gert Jan Meersma
  • ASAlbert J.H. Suurmeijer
    Albert J.H. Suurmeijer
  • JGJourik A. Gietema
    Jourik A. Gietema
  • MVMarcel A.T.M. van Vugt
    Marcel A.T.M. van Vugt
  • SJSteven de Jong
    Steven de Jong

Open Access
Publisher website
Google Scholar
  • 3 April 2023
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1535-7163.22507002.v1
Abstract
Cisplatin sensitivity in TC cells and RTK validation on western blot
Keywords
  • INHIBITION SENSITIZES
  • SUPPLEMENTARY FIGURE
  • SENSITIZES TESTICULAR
  • TESTICULAR CANCER
  • CANCER MODELS
  • CISPLATIN TREATMENT
  • TREATMENT CISPLATIN
  • RTK VALIDATION
  • WESTERN BLOT
  • CISPLATIN SENSITIVITY
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.